'Orange Book' Changes? US FDA Soliciting Comments On TE Codes

 
• By Derrick Gingery

The agency wants to know if the second letter in the product equivalence ratings system is helpful and whether changes could make the information more user-friendly.

Generics
The FDA also seeks comments on the potential changes to 'Orange Book' patent listing practices. • Source: Shutterstock

More from US FDA

More from Agency Leadership